Novaccess Global Inc Quick Ratio (XSNX) starting from the fourth quarter 2024 to fourth quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Novaccess Global Inc  (NONE: XSNX)

Novaccess Global Inc's Quick Ratio

XSNX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2024, Quick Ratio fell to 0 a new company low.

Within Major Pharmaceutical Preparations industry 542 other companies have achieved higher Quick Ratio than Novaccess Global Inc in fourth quarter 2024. While Quick Ratio total ranking in the fourth quarter 2024 has deteriorated compared to the prior quarter from 4802 to 5315.

Explain Quick Ratio?
How much Cash & cash equivalents XSNX´s has?
What are XSNX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XSNX Quick Ratio (Sep 30 2024)
Q4		 (Jun 30 2024)
Q3		 (Mar 31 2024)
Q2		 (Dec 31 2023)
Q1		 (Sep 30 2023)
Q4
Y / Y Current Liabilities Change 31.21 % 20.11 % 19.03 % -9.01 % 23.26 %
Y / Y Cash & cash equivalent Change -2.4 % -98.71 % -55.38 % -96.14 % -66.67 %
Quick Ratio MRQ 0 0 0 0 0
XSNX's Total Ranking # 5315 # 4802 # 2915 # 1937 # 4548
Seq. Current Liabilities Change 0.37 % 10.94 % 7.65 % 9.46 % -8.12 %
Seq. Cash & cash equivalent Change 2532.24 % -91.91 % 551.96 % -92.97 % -65.16 %



Quick Ratio fourth quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 543
Healthcare Sector # 1107
Overall Market # 5315


Quick Ratio Statistics
High Average Low
0.25 0.04 0
(Jun 30 2011)   (Sep 30 2020)




Financial Statements
Novaccess Global Inc's Current Liabilities $ 8 Millions Visit XSNX's Balance sheet
Novaccess Global Inc's Cash & cash equivalent $ 0 Millions Visit XSNX's Balance sheet
Source of XSNX's Sales Visit XSNX's Sales by Geography


Cumulative Novaccess Global Inc's Quick Ratio

XSNX's Quick Ratio for the trailling 12 Months

XSNX Quick Ratio

 (Sep 30 2024)
12 Months		 (Jun 30 2024)
12 Months		 (Mar 31 2024)
12 Months		 (Dec 31 2023)
12 Months		 (Sep 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 14.27 % 11.91 % 15.08 % 17 % 41.8 %
Y / Y Cash & cash equivalent TTM Growth -77.05 % -82.04 % -56.21 % -58.24 % -40.2 %
Quick Ratio TTM 0 0 0 0 0.01
Total Ranking TTM # 4171 # 3721 # 3719 # 3713 # 3535
Seq. Current Liabilities TTM Growth 6.81 % 5.02 % 4.51 % -2.53 % 4.61 %
Seq. Cash & cash equivalent TTM Growth -1.54 % -64.41 % -11.45 % -26.03 % -22.95 %

Quick ratio ranking by company, industry and sector >> Back to XSNX Financial Strength Comparisons >> Go to Compare XSNX Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q4 2024 to $7.73 millions, cumulative Quick Ratio